Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers
- PMID: 20139919
- PMCID: PMC2929361
- DOI: 10.1038/hr.2010.3
Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers
Abstract
Rho-associated kinases (ROCKs) have been shown to be involved in the pathogenesis of atherosclerosis. Although smoking is associated with endothelial dysfunction and ROCK inhibitors improve endothelial function in smokers, it is not known whether ROCK activity is increased in smokers and whether this correlates with endothelial dysfunction. The purpose of this study was to evaluate the relationship between ROCK activity and endothelial function in smokers. We evaluated flow-mediated vasodilatation (FMD) using ultrasonography and ROCK activity in peripheral leukocytes using western blot analysis in 14 male smokers (28.1+/-3.9 years) and 15 healthy male non-smokers (28.3+/-3.6 years). ROCK activity was defined as the ratio of phospho-myosin-binding subunit (MBS) on myosin light-chain phosphatase to total MBS. FMD was significantly less in smokers than in non-smokers (4.7+/-3.1 vs. 9.0+/-3.8%, P=0.005). Nitroglycerine-induced vasodilation was similar in the two groups. ROCK activity was greater in smokers than in non-smokers (0.78+/-0.27 vs. 0.54+/-018, P=0.012). The expression of total MBS, ROCK1 and ROCK2 were similar in the two groups. ROCK activity correlated with systolic blood pressure (r=0.42, P=0.039). Multiple regression analysis revealed that smoking is an independent predictor of ROCK activity. There was a significant correlation between FMD and ROCK activity (r=-0.42, P=0.035). No other variable was correlated with FMD. These findings suggest that ROCK activity is enhanced by smoking and is a predictor of endothelial function.
Conflict of interest statement
Dr James K Liao is a consultant for Asahi-Kasei Pharmaceutical.
Figures




Similar articles
-
Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2353-9. doi: 10.1161/ATVBAHA.111.227892. Epub 2011 Jul 7. Arterioscler Thromb Vasc Biol. 2011. PMID: 21737782 Free PMC article.
-
Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil.Atherosclerosis. 2011 Jan;214(1):117-21. doi: 10.1016/j.atherosclerosis.2010.10.005. Epub 2010 Oct 12. Atherosclerosis. 2011. PMID: 21035804 Free PMC article.
-
Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.Hypertension. 2015 Apr;65(4):841-8. doi: 10.1161/HYPERTENSIONAHA.114.05001. Epub 2015 Jan 26. Hypertension. 2015. PMID: 25624340 Free PMC article.
-
Effects of vitamin E on chronic and acute endothelial dysfunction in smokers.J Am Coll Cardiol. 2000 Feb;35(2):277-83. doi: 10.1016/s0735-1097(99)00542-2. J Am Coll Cardiol. 2000. PMID: 10676670 Clinical Trial.
-
The association between smoking exposure and endothelial function evaluated using flow-mediated dilation values: a meta-analysis.BMC Cardiovasc Disord. 2024 Jun 5;24(1):292. doi: 10.1186/s12872-024-03915-x. BMC Cardiovasc Disord. 2024. PMID: 38840064 Free PMC article.
Cited by
-
Increased Rho kinase activity in congestive heart failure.Eur J Heart Fail. 2012 Sep;14(9):965-73. doi: 10.1093/eurjhf/hfs068. Epub 2012 May 15. Eur J Heart Fail. 2012. PMID: 22588320 Free PMC article.
-
Coronary Spasm Testing with Acetylcholine: A Powerful Tool for a Personalized Therapy of Coronary Vasomotor Disorders.Life (Basel). 2024 Feb 22;14(3):292. doi: 10.3390/life14030292. Life (Basel). 2024. PMID: 38541619 Free PMC article. Review.
-
TLR9 expression is required for the development of cigarette smoke-induced emphysema in mice.Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L154-66. doi: 10.1152/ajplung.00073.2016. Epub 2016 Jun 10. Am J Physiol Lung Cell Mol Physiol. 2016. PMID: 27288485 Free PMC article.
-
Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.Trends Pharmacol Sci. 2011 Mar;32(3):167-73. doi: 10.1016/j.tips.2010.12.006. Epub 2011 Jan 16. Trends Pharmacol Sci. 2011. PMID: 21242007 Free PMC article. Review.
-
Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension.Clin Pharmacol Ther. 2012 Feb;91(2):289-97. doi: 10.1038/clpt.2011.227. Epub 2011 Dec 28. Clin Pharmacol Ther. 2012. PMID: 22205191 Free PMC article. Clinical Trial.
References
-
- Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto FJ, Tell GS. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. JAMA. 1998;279:119–124. - PubMed
-
- Tell GS, Polak JF, Ward BJ, Kittner SJ, Savage PJ, Robbins J. Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Study. The Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation. 1994;90:2905–2908. - PubMed
-
- Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation. 2001;104:1905–1910. - PubMed
-
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143. - PubMed
-
- Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150–155. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources